Lalantha Leelarathna

Imperial College Healthcare NHS Trust — United Kingdom

Medicine · Health Sciences

46h-index6.9kcitations179works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Management and Research(154), Pancreatic function and diabetes(105), Diabetes and associated disorders(84), Diabetes Treatment and Management(44), Hyperglycemia and glycemic control in critically ill and hospitalized patients(27)

Publications177 total

Real‐world glycaemic outcomes observed with the use of Medtronic <scp>780G</scp> , Tandem Control‐ <scp>IQ</scp> and Omnipod 5 automated insulin delivery systems
Diabetic Medicine·2026Open Access
Dialysis meets devices: the use of automated insulin delivery in end stage kidney disease and haemodialysis
Expert Review of Endocrinology & Metabolism·2026Open Access
Improving kidney transplant care through the application of continuous glucose monitoring - a narrative review
Frontiers in Nephrology·2025Open Access
Real‐world use of continuous glucose monitoring in people with type 2 diabetes and chronic kidney disease or on dialysis
Diabetic Medicine·2025Open Access
Managing Hybrid Closed-Loop Insulin Delivery in Complex Clinical Scenarios: Focus on Perioperative, Dialysis, and Glucocorticoid Use
Journal of Diabetes Science and Technology·2025
Efficacité et sécurité du système d’Administration Automatisé d’Insuline (AID) Omnipod 5 par rapport aux IMQ dans le traitement du diabète de type 1 : un essai contrôlé randomisé multinational (RADIANT)
Annales d Endocrinologie·2025
Using automated insulin delivery to address the clinical challenges of glycemic management in people with type 1 diabetes and kidney failure on maintenance hemodialysis
Journal of Diabetes Investigation·2025· 2 citedOpen Access
Fully closed‐loop control with ultra‐rapid versus standard insulin lispro: A randomised crossover study simulating missed meal boluses
Diabetic Medicine·2025· 2 citedOpen Access
314-OR: Improved Outcomes across Baseline Time-in-Range Levels with the Omnipod 5 AID System Compared with Multiple Daily Injections (MDI) in Type 1 Diabetes (T1D)—Analysis of the RADIANT Study
Diabetes·2025
Hybrid Closed-Loop Therapy in Adults with Type 1 Diabetes in England: Long-Term Outcomes from a Real-World Observational Study
Diabetes Technology & Therapeutics·2025· 1 citedOpen Access
Efficacy of the Omnipod® 5 Automated Insulin Delivery (AID) System Compared with Multiple Daily Injections in Type 1 Diabetes: A Multinational Randomized Controlled Trial (RADIANT)
Diabetologie und Stoffwechsel·2025
Impact of real-time glucose monitoring using FreeStyle Libre 3 on glycaemia in type 2 diabetes managed with basal insulin plus SGLT2 inhibitor and/or GLP-1 agonist: the FreeDM2 randomised controlled trial protocol
BMJ Open·2025Open Access
Insulin Delivery Hardware: Pumps and Pens
Diabetes Technology & Therapeutics·2025
Accuracy of the Dexcom G7 Continuous Glucose Monitoring Sensors in People with Diabetes Undergoing Hemodialysis (ALPHA-2 Study)
Diabetes Technology & Therapeutics·2025· 7 cited
Impact of Ultra-Rapid Insulin on Boost and Ease-Off in the Cambridge Hybrid Closed-Loop System for Individuals With Type 1 Diabetes
Journal of Diabetes Science and Technology·2024· 2 citedOpen Access
Continuous glucose sensor accuracy: beyond the headline metric
The Lancet Diabetes & Endocrinology·2024· 15 cited
Use of real‐time continuous glucose monitoring in non‐critical care insulin‐treated inpatients under non‐diabetes speciality teams in hospital: A pilot randomized controlled study
Diabetes Obesity and Metabolism·2024· 8 citedOpen Access
Author response for "Use of real-time continuous glucose monitoring in non-critical care insulin-treated inpatients under non-diabetes speciality teams in hospital: A pilot randomized controlled study"
2024
The use of technology in type 2 diabetes and prediabetes: a narrative review
Diabetologia·2024· 15 citedOpen Access
Update on recent advances in technology in type 1 diabetes
British Journal of Diabetes·2024· 1 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Hood Thabit(31), Roman Hovorka(28), Malgorzata E. Wilinska(23), Mark L. Evans(23), Janet M. Allen(20), David B. Dunger(14), Marianna Nodale(14), Kavita Kumareswaran(13), Julia K. Mader(12), Daniela Elleri(12), Carlo L. Acerini(11), Martin Tauschmann(10), Pratik Choudhary(10), Emma G. Wilmot(10), Karen Caldwell(10), Sara Hartnell(9), Simon Heller(9), Fiona Campbell(8), Sabine Arnolds(7), Thomas R. Pieber(7)